|
CNOT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.06421554796543E-14 |
| Normal-vs-Stage2 |
4.21589999999306E-06 |
| Normal-vs-Stage3 |
3.80806497446429E-14 |
| Normal-vs-Stage4 |
1.95476967945751E-12 |
| Stage1-vs-Stage2 |
2.730400E-01 |
| Stage1-vs-Stage3 |
1.802800E-01 |
| Stage1-vs-Stage4 |
5.958200E-02 |
| Stage2-vs-Stage3 |
6.578400E-02 |
| Stage2-vs-Stage4 |
2.626200E-02 |
| Stage3-vs-Stage4 |
4.133200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99200722162641E-16 |
| Normal-vs-AfricanAmerican |
3.00050000001661E-06 |
| Normal-vs-Asian |
1.72709957446671E-10 |
| Caucasian-vs-AfricanAmerican |
5.787000E-01 |
| Caucasian-vs-Asian |
7.982000E-01 |
| AfricanAmerican-vs-Asian |
4.520800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96953564568503E-13 |
| Normal-vs-Female |
1.62625468647093E-12 |
| Male-vs-Female |
6.773800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.81774603649865E-12 |
| Normal-vs-Age(41-60Yrs) |
4.63962201990853E-13 |
| Normal-vs-Age(61-80Yrs) |
1.67732494560369E-12 |
| Normal-vs-Age(81-100Yrs) |
7.80150000000424E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.996400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.903600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.085200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.474800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.791800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.343400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.481180E-01 |
| Classical-VS-Follicular |
3.206000E-01 |
| Classical-VS-Other |
1.957550E-01 |
| Classical-VS-Normal |
1.63002944475465E-12 |
| Tall-VS-Follicular |
5.459600E-01 |
| Tall-VS-Other |
5.593200E-01 |
| Tall-VS-Normal |
1.17179999037376E-09 |
| Follicular-VS-Other |
4.971600E-01 |
| Follicular-VS-Normal |
7.55779994143779E-10 |
| Other-VS-Normal |
1.383510E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.61914967281518E-13 |
| Normal-vs-N1 |
2.4535928844216E-14 |
| N0-vs-N1 |
9.637300E-03 |
|
|
